Newsletter Subject

PURE Healthy Diet Sees Advantage by Promoting Whole-Fat Dairy for Heart Health

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Jul 7, 2023 10:53 PM

Email Preheader Text

Daily Headlines Friday, July 07, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT TH

[MEDPAGE TODAY]( Daily Headlines Friday, July 07, 2023 Today's Top Stories for {NAME} [PRIMARY CARE]( [PURE Healthy Diet Sees Advantage by Promoting Whole-Fat Dairy for Heart Health]( [OPHTHALMOLOGY]( [Favorable Long-Term Results With Ranibizumab Implant for Neovascular AMD]( [RADIOLOGY]( [IMRT Dosing Strategy Eases Dysphagia in Head and Neck Cancer]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Transforming Treatment and Management Strategies for Patients With AML]( [SPECIAL REPORTS]( [Top Misconceptions About Heat Illness, From an EMT in the Hottest Place on Earth]( [NEUROLOGY]( [Adapted CAR-T Therapy Shows Promise in Myasthenia Gravis]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [PRIMARY CARE]( [Places With Smoke-Free Laws Have the Best Health Outcomes]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( [PUBLIC HEALTH & POLICY]( [Biden Administration Proposes Rule Cracking Down on Short-Term Health Plans]( [POP MEDICINE]( [Treating a Double Trouble Shark Attack]( [MEETING COVERAGE]( [Targeted Therapies for Non-Clear Cell Renal Cell Carcinoma]( CME SPOTLIGHT [Clinical Evidence for Current and Emerging Therapies in Relapsed/Refractory Multiple Myeloma]( [SPECIAL REPORTS]( [Wisconsin Ob/Gyn Surrenders Medical License After Patient's Death]( [MEETING COVERAGE]( [Can a Simple Beta-Blocker Improve Immunotherapy Responses?]( [MEETING COVERAGE]( [New Treatment for Recurrent Ovarian Cancer Improves Survival]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [MEETING COVERAGE]( [STRIDE Regimen Shows Manageable Safety in Unresectable Liver Cancer]( [ONCOLOGY/HEMATOLOGY]( [Strategies for Chemo Shortages; HPV Testing for Older Women; Drug-Pricing Battles]( [RHEUMATOLOGY]( [Imaging for Back and Joint Pain: Overuse Is an International Problem]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( [PUBLIC HEALTH & POLICY]( [FDA Appears to Mostly Follow Its Drug Advisory Committees' Advice]( [OPINION]( [Dear New Residents, Medicine Is a Hard and Beautiful Gift]( [ASCO READING ROOM]( [Lung Cancer and Depression: A Global Issue That Needs More Attention]( CME SPOTLIGHT [Treatment and Management of Patients with HER2+ Advanced/Metastatic Breast Cancer]( [ASCO READING ROOM]( [Thoughtful Review on Challenges and Opportunities in Cancer Survivorship in the Indo-Pacific]( [PRIMARY CARE]( ['Overweight' BMI Not Tied to Higher Risk of Death, U.S. Data Suggest]( [PRACTICE MANAGEMENT]( [What Not to Do When Starting a Private Practice]( # Weekly Survey [SCOTUS Affirmative Action Ruling: Yea or Nay?]( Physician and other healthcare organizations [panned the Supreme Court's recent decision]( striking down the use of affirmative action policies in college admissions[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-07-07&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.